NSE filing, NSE: DIVISLAB. Summary written from the filing by ALFA Finder's alert engine.
Divi's Laboratories Ltd: key numbers
- Share price
- ₹10,140.50
- Market cap
- ₹2,69,198 Cr
- Revenue (annual)
- ₹10,560 Cr
- Net profit (annual)
- ₹2,568 Cr
- P/E (TTM)
- 92.0×Sector 42.0×
- Promoter holding
- 51.88%+0.00% QoQ
- FII holding
- 20.38%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Divi's Laboratories Ltd
All →Divi's Laboratories Board Meeting Date
Divi's Laboratories will hold a board meeting on November 07, 2026, to approve unaudited standalone and consolidated financial results for the quarter ended September 30, 2026.
Divi's Laboratories Other Announcement
Divis Laboratories Ltd has submitted its quarterly shareholding pattern as of September 30, 2026, in compliance with SEBI Regulation 31.
Divi's Laboratories Other Announcement
Immediate relatives of the company purchased 462 shares for a total consideration of Rs. 0.43 Crore in the open market.
- Value
- ₹0.43 Cr
Divi's Laboratories Other Announcement
Divis Laboratories Ltd reported a share pledge by Designated Person Nimmagadda Venkata Anirudh involving securities valued at ₹3.33 Crore. Additionally, Joshita Divi acquired shares worth ₹0.96 Crore via market purchase.
- Value
- ₹4.29 Cr
Divi's Laboratories Other Announcement
An immediate relative of a Divis Laboratories promoter bought equity shares worth ₹0.58 Crore through a market purchase.
- Value
- ₹0.58 Cr
Divi's Laboratories Other Announcement
Designated Person PRASAD Y.T.S. disclosed the release of two share pledges involving 2,734 equity shares. The combined transaction value of the released pledges is Rs. 2.56 Crore.
- Value
- ₹2.56 Cr
Other management change announcements
All →Ceat Management Change
CEAT Limited has issued a postal ballot notice seeking shareholder approval to appoint Mr. Sumeet Narang as a Non-Executive Independent Director. E-voting runs 7 Nov to 6 Dec 2026.
Sai Life Science Management Change
Sai Life Sciences appointed three senior management personnel effective 5 November 2026. The appointees include Sidhartha Das as Senior Vice President and Head of Human Resources.
Karamtara Engineering Management Change
Karamtara Engineering appointed Ajoy Mehta and Sanjeeb Chaudhuri as Non-Executive Independent Directors effective November 5, 2026. Each appointment is for a 60-month term.
- Execution
- 60 months
Nimbus Projects Management Change
Nimbus Projects Ltd's Chairman Bipin Agarwal is stepping down from the Chairman role effective November 5, 2026, while remaining Managing Director. No change to his directorship, MD role or remuneration.
Shyam Century Ferrous Management Change
Shyam Century Ferrous's Company Secretary Ritu Agarwal resigned, effective November 30, 2026, citing personal reasons. The resignation letter was received October 16, 2026.
Kalpataru Projects International Management Change
Kalpataru Projects approved the appointment of Amit Uplenchwar as Joint Managing Director and CEO, effective January 1, 2027. The five-year term is subject to shareholder approval.
- Execution
- January 1, 2027 to December 31, 2031